New Cervical Cancer Screening Guidelines Released Screening Should Begin At Age 25 And Be Conducted Every 3 Years
1/10/2013

Routine screening of women for cervical cancer should begin at age 25 and be conducted at 3-year intervals, recommend new screening guidelines from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal).The guidelines also recommend screening for women aged 70 years and older who have not been adequately screened in the past...

Centralisation To Fewer Surgeons Results In Better Survival After Oesophageal Cancer Surgery
1/10/2013

Patients who undergo surgery for oesophageal cancer have a much greater chance of long term survival if the operation is carried out by a surgeon who has performed this particular operation many times before. This according to a new, large-scale study conducted by researchers at Karolinska Institutet in Sweden, which is published in the Journal of Clinical Oncology...

Cancer Screening Unlikely To Benefit Patients With A Short Life Expectancy
1/10/2013

Less than 10 years and risks are likely to outweigh benefits Breast and colorectal cancer screening should be targeted towards patients with a life expectancy greater than 10 years: for any shorter life expectancy the harms are likely to outweigh the benefits, concludes a study published on bmj.com today...

Surprising Influences On Cancer Screenings Revealed By First Study Of Oregon's Hmong
1/10/2013

Cervical cancer rates for Hmong women are among the highest in the nation, yet past research has shown that cervical and breast cancer screening rates for this population are low - in part because of the Hmong's strong patriarchal culture...

Genetic Region Linked To Control Of Key Blood-Clotting Protein Discovered Through Sibling Study
1/10/2013

In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders. The samples were collected over three years and have now enabled the researchers to identify the specific parts of the genome responsible for levels of a key substance for blood clotting...

BMJ Raises Concerns Over The Effectiveness Of A Costly And Invasive Procedure For Melanoma
1/10/2013

BMJ Editor says all trials must be registered and the results published A special report published by the BMJ today finds that thousands of melanoma patients around the world are undergoing an expensive and invasive procedure called sentinel node biopsy, despite a lack of clear evidence and concerns that it may do more harm than good...

New Cervical Cancer Screening Guidelines Released Screening Should Begin At Age 25 And Be Conducted Every 3 Years
1/10/2013

Routine screening of women for cervical cancer should begin at age 25 and be conducted at 3-year intervals, recommend new screening guidelines from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal).The guidelines also recommend screening for women aged 70 years and older who have not been adequately screened in the past...

Surprising Influences On Cancer Screenings Revealed By First Study Of Oregon's Hmong
1/10/2013

Cervical cancer rates for Hmong women are among the highest in the nation, yet past research has shown that cervical and breast cancer screening rates for this population are low - in part because of the Hmong's strong patriarchal culture...

Cancer Death Rates Have Fallen Over The Last Decade
1/09/2013

Overall cancer death rates in the U.S. have been steadily declining, according to latest data gathered from The Annual Report to the Nation on the Status of Cancer. The report, which analyzed the number of deaths caused by cancer from 1975-2009, has shed light on the extent of the country's success in its battle against cancer...

Provectus Pharmaceuticals Announces H. Lee Moffitt Cancer Center Initiates Phase 1 Study Of PV-10 To Elucidate Bystander Effect
1/09/2013

Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional ("IL") PV-10 injection of melanoma tumors. Amod Sarnaik, M.D...